Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy

被引：0
|
作者：
Robert, C.
Chaput, N.
Lassau, N.
Auperin, A.
Koscielny, S.
Hollville, E.
Lazar, V.
Lacroix, L.
Soria, J.
Mateus, C.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, Dept Biopathol, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.8552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8552
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I/II trial of the combination of bevacizumab, oxaliplatin, and sorafenib in patients with metastatic melanoma
    McClay, E. F.
    Bessudo, A.
    Frakes, L.
    Eisenberg, S.
    Just, R.
    Banerjee, P.
    Sinclair, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial
    Tas, F
    Argon, A
    Camlica, H
    Topuz, E
    MELANOMA RESEARCH, 2005, 15 (06) : 543 - 548
  • [3] Phase I/II study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma
    Kim, K. B.
    Davies, M. A.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Hwu, W.
    Woodard, K.
    Washington, E. W.
    Dancey, J. E.
    Wright, J.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
    Tawbi, H. A.
    Beumer, J. H.
    Tarhini, A. A.
    Moschos, S.
    Buch, S. C.
    Egorin, M. J.
    Lin, Y.
    Christner, S.
    Kirkwood, J. M.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 1112 - 1119
  • [5] Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
    Davies, Michael A.
    Fox, Patricia S.
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Hwu, Wen-Jen
    Lazar, Alexander J.
    Prieto, Victor G.
    Culotta, Kirk S.
    Madden, Timothy L.
    Xu, Quanyun
    Huang, Sha
    Deng, Wanleng
    Ng, Chaan S.
    Gupta, Sanjay
    Liu, Wenbin
    Dancey, Janet E.
    Wright, John J.
    Bassett, Roland L.
    Hwu, Patrick
    Kim, Kevin B.
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 1120 - 1128
  • [6] Phase I trial of imatinib and temozolomide in patients with metastatic melanoma.
    Schuchter, L
    Flaherty, K
    Davidson, R
    Cavallaro, L
    Hendricks, M
    Deming, P
    Recio, A
    Tuveson, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 728S - 728S
  • [7] Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
    Wierzbicka-Hainaut, Ewa
    Sassolas, Bruno
    Mourey, Laurent
    Guillot, Bernard
    Bedane, Christophe
    Guillet, Gerard
    Tourani, Jean Marc
    MELANOMA RESEARCH, 2010, 20 (02) : 141 - 146
  • [8] Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    McDermott, David F.
    Kramer, Amy
    Giles, Lydia
    Gramlich, Kristi
    Carberry, Mary
    Troxel, Andrea B.
    Letrero, Richard
    Nathanson, Katherine L.
    Atkins, Michael B.
    O'Dwyer, Peter J.
    Flaherty, Keith T.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7711 - 7718
  • [9] PHASE I STUDY OF THE COMBINATION OF DOCETAXEL, TEMOZOLOMIDE AND CISPLATIN IN PATIENTS WITH METASTATIC MELANOMA
    Kim, K. B.
    Hwu, W. J.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Camacho, L. H.
    Ng, C.
    Hernandez, I.
    Frost, A. M.
    Jack, M.
    Hwu, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [10] A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
    McQuade, Jennifer L.
    Posada, Liberty P.
    Lecagoonporn, Srisuda
    Cain, Suzanne
    Bassett, Roland L., Jr.
    Patel, Sapna P.
    Hwu, Wen-Jen
    Hwu, Patrick
    Davies, Michael A.
    Bedikian, Agop Y.
    Amaria, Rodabe N.
    MELANOMA RESEARCH, 2016, 26 (06) : 604 - 608
12345